You are here

FSD Pharma Inc. Subordinate Voting Shares

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
HUGE
CSE Index: 
Currency: 

FSD Pharma Inc. is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting Multiple Sclerosis, LUCID-PSYCH, a psychoactive molecule targeting Major Depressive Disorder, and FSD-PEA, an ultra-micronized Palmitoyl ethylamine with a favorable safety profile targeting inflammation.

 

You are here

FSD Pharma Inc. Subordinate Voting Shares (HUGE)

SEDAR Information

Company Info

Address
199 Bay Street
Suite 4000
Toronto, ON M5L 1A9
Canada
Phone
844-978-3540
Email
info@fsdpharma.com
Website
https://www.fsdpharma.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
Marrelli Trust Company Limited
Investor Relations
Zeeshan Saeed
Email
IR@fsdpharma.com
Auditor
MNP LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
38,309,717
Reserved for Issuance: 
48,281,682

Company Officers

Anthony Durkacz, Founder & Executive Co-Chairman
Zeeshan Saeed, Founder & Executive Co-Chairman

Bulletins

11/10/2019

2019-1006 – Consolidation - FSD Pharma Inc. Subordinate Voting Shares (HUGE)

le 11 octobre/October 2019

FSD Pharma Inc. has announced a consolidation of its Class B Subordinate Voting shares on the basis  of one (1) post-consolidation common share for every two hundred one (201) pre-consolidation common shares.

As a result, the outstanding shares of the company will be reduced to approximately 7,874,809.

The shares will begin trading on a consolidated basis and with a new CUSIP number on October 16, 2019.

The name and symbol will not change.

Advertisement

Publicité

Latest CSE News

Upcoming Events

cse_v2.png

27th Annual CSTA Conference

Thursday, August 18, 2022 - 1:30pm to Sunday, August 21, 2022 - 11:00am